Teva (TEVA) Hits Session Lows as Biogen (BIIB) MS Pill Gains Approval
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
JMP Securities Starts Biogen (BIIB) at Market Outperform
March 28, 2013 7:13 AM EDTJMP Securities initiates coverage on Biogen (NASDAQ: BIIB) with a Market Outperform. PT $203.00.
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $182.68 yesterday, with a 52 week range of $124.23-$184.17.... More
What Next for Biogen (BIIB)? Anlaysts Weigh In
March 27, 2013 5:43 PM EDTOn Tuesday Biogen's (NASDAQ: BIIB) Tecfidera/BG12 was approved by the FDA. In addition to approval, the drug's label is considered "clean" .
Commenting on news, analyst Brian Abrahams of Wells Fargo said, "Overall the label reads relatively favorably, in our view, as expected . . . all eyes will now... More
Biogen Idec (BIIB) Affirms Receipt of FDA Approval for TECFIDERA as MS Treatment
March 27, 2013 4:25 PM EDTToday Biogen Idec (NASDAQ: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved TECFIDERA (dimethyl fumarate), a new first-line oral treatment for people with relapsing forms of multiple sclerosis (MS). Biogen Idec will make this oral capsule available to people living with MS in the United States in the coming days.
TECFIDERA has... More
XenoPort (XNPT) Pops Higher on Biogen (BIIB) Tecfidera Approval
March 27, 2013 3:54 PM EDTXenoPort, Inc. (NASDAQ: XNPT) shares are seeing some upside as the FDA approved Boigen's (Nasdaq: BIIB) Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis (MS).
Shares are up 0.8 percent.... More
